Literature DB >> 25301129

[Dyslalias associated to maloclussion in schoolchildren].

Adriana Vázquez-Reyes1, Adriana Reyes Y Zepeda, Angeles Moyaho-Bernal, Alicia Moreno-García, Alvaro José Montiel-Jarquín, Ana Karen Hernández-Ruíz, Ruth Bejarano-Huertas, Aurelio López-Colombo.   

Abstract

BACKGROUND: The test for evaluating phonological simplification processes (TEPROSIF, according to its initials in Spanish) is a tool which is used to identify dyslalias. Our objective was to establish, by using TEPROSIF, the association between dyslalias and malocclusion in children from 4 to 6 years of age.
METHODS: After we standardized the tool with a kappa of 0.9, we applied it to 116 children from 4 to 6 years of age. Patients were conducted to a central occlusion through deglutition. We observed type of bite, overbite, occlusion and terminal plane in order to relate them to the dyslalia presented. For statistical analysis, we used chi-squared test (p < 0.05).
RESULTS: They were 55 (47.4 %) boys and 61 (52.6 %) girls, with a median age of 5 years ± 0.71. Phoneme substitution was the most common alteration. We found significant correlation between omission of the phonemes and terminal plane (p = 0.01), Baume type I arch (p = 0.00) and absence of teeth (p = 0.00), as well as between phoneme substitution and terminal plane (p = 0.03), bite type (p = 0.01) and absence of teeth (p = 0.00).
CONCLUSIONS: Phoneme substitution is the most common alteration, followed by omission and distortion of phonemes in children between 4 and 6 years of age.

Entities:  

Keywords:  Articulation disorders; Malocclusion; Speech disorders

Mesh:

Year:  2014        PMID: 25301129

Source DB:  PubMed          Journal:  Rev Med Inst Mex Seguro Soc        ISSN: 0443-5117


  1 in total

1.  Association between malocclusion and articulation of phonemes in early childhood.

Authors:  Omaya Amr-Rey; Purificación Sánchez-Delgado; Rosario Salvador-Palmer; Rosa Cibrián; Vanessa Paredes-Gallardo
Journal:  Angle Orthod       Date:  2022-07-01       Impact factor: 2.684

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.